Cell & Gene: The Podcast by Erin Harris

107 - Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath

Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.

More episodes

107 - Gene Therapy for Inherited Retinal Diseases with Opus Genetics' Dr. George Magrath

Thu, 03 Jul 2025
106 - Extracellular Vesicle Breakthroughs with Aegle Therapeutics' Dr. Gloria Matthews

Thu, 19 Jun 2025
105 - Bridging Development and Regulation in CGT with Halloran Consulting Group's Monika Swietlicka

Thu, 05 Jun 2025
104 - Harnessing AI and Synthetic Biology for Cell Therapies with Generate:Biomedicines' Dr. Alex Snyder

Thu, 22 May 2025
103 - Redefining Heart Failure Treatment with Precision Autologous Cell Therapy with BioCardia's Peter Altman, Ph.D.

Thu, 08 May 2025
102 - CRI’s Response to NIH Cuts with Alicia Zhou, Ph.D.

Thu, 24 Apr 2025
101 - Rethinking CGT Biotech Growth & Investment with Audrey Greenberg

Thu, 10 Apr 2025
100 - Advancing Retinal Gene Therapy with Atsena Therapeutics' Dr. Kenji Fujita

Thu, 27 Mar 2025
99 - Harnessing the Power of Cord Blood Tregs with Cellenkos' Dr. Simrit Parmar

Thu, 13 Mar 2025
98 - CGT Manufacturing: Distributed & Digital with Deloitte Consulting's Omkar Kawalekar, Ph.D.

Thu, 27 Feb 2025
97 - Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

Thu, 13 Feb 2025
96 - The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.

Thu, 30 Jan 2025
95 - The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

Thu, 16 Jan 2025
94 - Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

Thu, 02 Jan 2025
93 - Can Gene Therapy Be the Solution for CHF with AskBio's Dr. Lothar Roessig

Thu, 19 Dec 2024
92 - Inside a Dopamine-Restoring Cell Therapy for PD with BlueRock Therapeutics' Dr. Amit Rahkit

Thu, 05 Dec 2024
91 - Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

Thu, 21 Nov 2024
90 - Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

Thu, 07 Nov 2024
89 - Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

Thu, 24 Oct 2024
88 - Pioneering Next-Gen TCR Therapies in Solid Tumors with Neogene Therapeutics’ Carsten Linnemann, Ph.D.

Thu, 10 Oct 2024
87 - Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

Wed, 25 Sep 2024
86 - A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino

Thu, 12 Sep 2024
85 - Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts

Thu, 29 Aug 2024
84 - CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

Thu, 15 Aug 2024
83 - Identifying Drug Development Opportunities for DMD with CureDuchenne

Thu, 01 Aug 2024
82 - Tackling "The Delivery Problem" of Gene Editing-Based Medicines with Mammoth Biosciences' Lucas Harrington

Thu, 18 Jul 2024
81 - TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

Thu, 04 Jul 2024
80 - Synthetic Biology and Programmable mRNA with Strand Therapeutics' Jake Becraft

Thu, 20 Jun 2024
79 - Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

Thu, 06 Jun 2024
78 - The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley

Tue, 28 May 2024
77 - Dr. Bruce Levine on ISCT and the Future of CAR-T

Thu, 23 May 2024
76 - CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

Thu, 09 May 2024
75 - Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

Thu, 25 Apr 2024
74 - Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

Thu, 11 Apr 2024
73 - Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

Thu, 28 Mar 2024
72 - Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

Thu, 14 Mar 2024
71 - The Future of Rare Diseases with The Jackson Laboratory’s Rare Disease Translational Center's Cat Lutz

Thu, 29 Feb 2024
70 - Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead company's Christopher McDonald

Thu, 15 Feb 2024
69 - Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.

Thu, 01 Feb 2024
68 - Breaking Down Solid Tumors with Triumvira Immunologics' Dr. Paul Lammers

Thu, 18 Jan 2024
67 - 4 Keys to Allo in 2024 with Poseida Therapeutics' Kristin Yarema, Ph.D.

Thu, 04 Jan 2024
66 - Cell Therapy For Corneal Endothelial Dystrophies With Aurion Biotech's Greg Kunst

Thu, 21 Dec 2023
65 - Overcoming the Limitations of CAR T-Cell Therapy with Vittoria Bio's Nick Siciliano, Ph.D.

Thu, 07 Dec 2023
64 - Gene Therapy Deals, Collaborations, & Partnerships with Astellas' Richard Wilson

Tue, 21 Nov 2023
63 - The Promise of AAV Gene Therapy with REGENXBIO's Ken Mills

Thu, 09 Nov 2023
62 - Inside 2023 Meeting on the Mesa with ARM's COO, Rita Johnson-Greene

Thu, 26 Oct 2023
61 - The Future of Cell and Organ Transplantation in Treating T1D with Dr. Camillo Ricordi

Thu, 12 Oct 2023
60 - In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg

Thu, 28 Sep 2023
59 - Inside Genome Editing with CBER's Dr. Peter Marks

Thu, 14 Sep 2023
58 - The Future of CAR-T with Bristol Myers Squibb's Lynelle Hoch

Thu, 31 Aug 2023

Show more episodes

More science & medicine podcasts

More science & medicine international podcasts

Find your radio station